- Presentations
- 2
- Markets
- 1
Tembexa is a brand of Brincidofovir marketed by Emergent BioDefense Operations Lansing, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Brincidofovir
- Brand owner
- Emergent BioDefense Operations Lansing
- Registered in
- United States
- Strengths and forms
- 10 mg/mL oral suspension, 100 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tembexa 10 mg/mL oral suspensionOral | Emergent BioDefense Operations Lansing | US FDA | Available on request |
| Tembexa 100 mg tabletOral | Emergent BioDefense Operations Lansing | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tembexa
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.